Click for best price
Lysosomal Storage Disorders Market Size, Share 2024
The global Lysosomal Storage Disorders market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Lysosomal Storage Disorderseter market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Lysosomal Storage Disorders market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Lysosomal Storage Disorders market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Enzyme Replacement Therapy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Lysosomal Storage Disorders include Astellas Pharma, Astrazeneca, Actelion, Eli Lilly and Company, Merck & Co, Novo Nordisk, Amicus Therapeutics, Pfizer and Sanofi, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Lysosomal storage diseases or disorders (LSDs) are?rare genetic conditions that cause a buildup of toxic materials in your body's cells. People with LSDs lack certain enzymes or a substance that helps the enzyme work (enzyme activator or modifier).
This report aims to provide a comprehensive presentation of the global market for Lysosomal Storage Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lysosomal Storage Disorders. This report contains market size and forecasts of Lysosomal Storage Disorders in global, including the following market information:
Global Lysosomal Storage Disorders Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We has surveyed the Lysosomal Storage Disorders companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lysosomal Storage Disorders Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Lysosomal Storage Disorders Market Segment Percentages, by Type, 2023 (%)
- Enzyme Replacement Therapy
- Stem Cell Therapy
- Substrate Reduction Therapy
- Chaperone Therapy
- Others
Global Lysosomal Storage Disorders Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Lysosomal Storage Disorders Market Segment Percentages, by Application, 2023 (%)
- Hospital
- Clinics
- Stem Cell Transplant Centre
- Research Institutes
- Others
Global Lysosomal Storage Disorders Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Lysosomal Storage Disorders Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Lysosomal Storage Disorders revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Lysosomal Storage Disorders revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Astellas Pharma
- Astrazeneca
- Actelion
- Eli Lilly and Company
- Merck & Co
- Novo Nordisk
- Amicus Therapeutics
- Pfizer
- Sanofi
- BioMarin Pharmaceutical Inc.
- Raptor Pharmaceuticals
- Protalix Biotherapeutics Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lysosomal Storage Disorders, market overview.
Chapter 2: Global Lysosomal Storage Disorders market size in revenue.
Chapter 3: Detailed analysis of Lysosomal Storage Disorders company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lysosomal Storage Disorders in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Lysosomal Storage Disorders Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Lysosomal Storage Disorders Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lysosomal Storage Disorders Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lysosomal Storage Disorders Overall Market Size
2.1 Global Lysosomal Storage Disorders Market Size: 2023 VS 2030
2.2 Global Lysosomal Storage Disorders Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lysosomal Storage Disorders Players in Global Market
3.2 Top Global Lysosomal Storage Disorders Companies Ranked by Revenue
3.3 Global Lysosomal Storage Disorders Revenue by Companies
3.4 Top 3 and Top 5 Lysosomal Storage Disorders Companies in Global Market, by Revenue in 2023
3.5 Global Companies Lysosomal Storage Disorders Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lysosomal Storage Disorders Players in Global Market
3.6.1 List of Global Tier 1 Lysosomal Storage Disorders Companies
3.6.2 List of Global Tier 2 and Tier 3 Lysosomal Storage Disorders Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Lysosomal Storage Disorders Market Size Markets, 2023 & 2030
4.1.2 Enzyme Replacement Therapy
4.1.3 Stem Cell Therapy
4.1.4 Substrate Reduction Therapy
4.1.5 Chaperone Therapy
4.1.6 Others
4.2 By Type - Global Lysosomal Storage Disorders Revenue & Forecasts
4.2.1 By Type - Global Lysosomal Storage Disorders Revenue, 2019-2024
4.2.2 By Type - Global Lysosomal Storage Disorders Revenue, 2025-2030
4.2.3 By Type - Global Lysosomal Storage Disorders Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lysosomal Storage Disorders Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Stem Cell Transplant Centre
5.1.5 Research Institutes
5.1.6 Others
5.2 By Application - Global Lysosomal Storage Disorders Revenue & Forecasts
5.2.1 By Application - Global Lysosomal Storage Disorders Revenue, 2019-2024
5.2.2 By Application - Global Lysosomal Storage Disorders Revenue, 2025-2030
5.2.3 By Application - Global Lysosomal Storage Disorders Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Lysosomal Storage Disorders Market Size, 2023 & 2030
6.2 By Region - Global Lysosomal Storage Disorders Revenue & Forecasts
6.2.1 By Region - Global Lysosomal Storage Disorders Revenue, 2019-2024
6.2.2 By Region - Global Lysosomal Storage Disorders Revenue, 2025-2030
6.2.3 By Region - Global Lysosomal Storage Disorders Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Lysosomal Storage Disorders Revenue, 2019-2030
6.3.2 US Lysosomal Storage Disorders Market Size, 2019-2030
6.3.3 Canada Lysosomal Storage Disorders Market Size, 2019-2030
6.3.4 Mexico Lysosomal Storage Disorders Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Lysosomal Storage Disorders Revenue, 2019-2030
6.4.2 Germany Lysosomal Storage Disorders Market Size, 2019-2030
6.4.3 France Lysosomal Storage Disorders Market Size, 2019-2030
6.4.4 U.K. Lysosomal Storage Disorders Market Size, 2019-2030
6.4.5 Italy Lysosomal Storage Disorders Market Size, 2019-2030
6.4.6 Russia Lysosomal Storage Disorders Market Size, 2019-2030
6.4.7 Nordic Countries Lysosomal Storage Disorders Market Size, 2019-2030
6.4.8 Benelux Lysosomal Storage Disorders Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Lysosomal Storage Disorders Revenue, 2019-2030
6.5.2 China Lysosomal Storage Disorders Market Size, 2019-2030
6.5.3 Japan Lysosomal Storage Disorders Market Size, 2019-2030
6.5.4 South Korea Lysosomal Storage Disorders Market Size, 2019-2030
6.5.5 Southeast Asia Lysosomal Storage Disorders Market Size, 2019-2030
6.5.6 India Lysosomal Storage Disorders Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Lysosomal Storage Disorders Revenue, 2019-2030
6.6.2 Brazil Lysosomal Storage Disorders Market Size, 2019-2030
6.6.3 Argentina Lysosomal Storage Disorders Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lysosomal Storage Disorders Revenue, 2019-2030
6.7.2 Turkey Lysosomal Storage Disorders Market Size, 2019-2030
6.7.3 Israel Lysosomal Storage Disorders Market Size, 2019-2030
6.7.4 Saudi Arabia Lysosomal Storage Disorders Market Size, 2019-2030
6.7.5 UAE Lysosomal Storage Disorders Market Size, 2019-2030
7 Lysosomal Storage Disorders Companies Profiles
7.1 Astellas Pharma
7.1.1 Astellas Pharma Company Summary
7.1.2 Astellas Pharma Business Overview
7.1.3 Astellas Pharma Lysosomal Storage Disorders Major Product Offerings
7.1.4 Astellas Pharma Lysosomal Storage Disorders Revenue in Global Market (2019-2024)
7.1.5 Astellas Pharma Key News & Latest Developments
7.2 Astrazeneca
7.2.1 Astrazeneca Company Summary
7.2.2 Astrazeneca Business Overview
7.2.3 Astrazeneca Lysosomal Storage Disorders Major Product Offerings
7.2.4 Astrazeneca Lysosomal Storage Disorders Revenue in Global Market (2019-2024)
7.2.5 Astrazeneca Key News & Latest Developments
7.3 Actelion
7.3.1 Actelion Company Summary
7.3.2 Actelion Business Overview
7.3.3 Actelion Lysosomal Storage Disorders Major Product Offerings
7.3.4 Actelion Lysosomal Storage Disorders Revenue in Global Market (2019-2024)
7.3.5 Actelion Key News & Latest Developments
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Company Summary
7.4.2 Eli Lilly and Company Business Overview
7.4.3 Eli Lilly and Company Lysosomal Storage Disorders Major Product Offerings
7.4.4 Eli Lilly and Company Lysosomal Storage Disorders Revenue in Global Market (2019-2024)
7.4.5 Eli Lilly and Company Key News & Latest Developments
7.5 Merck & Co
7.5.1 Merck & Co Company Summary
7.5.2 Merck & Co Business Overview
7.5.3 Merck & Co Lysosomal Storage Disorders Major Product Offerings
7.5.4 Merck & Co Lysosomal Storage Disorders Revenue in Global Market (2019-2024)
7.5.5 Merck & Co Key News & Latest Developments
7.6 Novo Nordisk
7.6.1 Novo Nordisk Company Summary
7.6.2 Novo Nordisk Business Overview
7.6.3 Novo Nordisk Lysosomal Storage Disorders Major Product Offerings
7.6.4 Novo Nordisk Lysosomal Storage Disorders Revenue in Global Market (2019-2024)
7.6.5 Novo Nordisk Key News & Latest Developments
7.7 Amicus Therapeutics
7.7.1 Amicus Therapeutics Company Summary
7.7.2 Amicus Therapeutics Business Overview
7.7.3 Amicus Therapeutics Lysosomal Storage Disorders Major Product Offerings
7.7.4 Amicus Therapeutics Lysosomal Storage Disorders Revenue in Global Market (2019-2024)
7.7.5 Amicus Therapeutics Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Lysosomal Storage Disorders Major Product Offerings
7.8.4 Pfizer Lysosomal Storage Disorders Revenue in Global Market (2019-2024)
7.8.5 Pfizer Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Lysosomal Storage Disorders Major Product Offerings
7.9.4 Sanofi Lysosomal Storage Disorders Revenue in Global Market (2019-2024)
7.9.5 Sanofi Key News & Latest Developments
7.10 BioMarin Pharmaceutical Inc.
7.10.1 BioMarin Pharmaceutical Inc. Company Summary
7.10.2 BioMarin Pharmaceutical Inc. Business Overview
7.10.3 BioMarin Pharmaceutical Inc. Lysosomal Storage Disorders Major Product Offerings
7.10.4 BioMarin Pharmaceutical Inc. Lysosomal Storage Disorders Revenue in Global Market (2019-2024)
7.10.5 BioMarin Pharmaceutical Inc. Key News & Latest Developments
7.11 Raptor Pharmaceuticals
7.11.1 Raptor Pharmaceuticals Company Summary
7.11.2 Raptor Pharmaceuticals Business Overview
7.11.3 Raptor Pharmaceuticals Lysosomal Storage Disorders Major Product Offerings
7.11.4 Raptor Pharmaceuticals Lysosomal Storage Disorders Revenue in Global Market (2019-2024)
7.11.5 Raptor Pharmaceuticals Key News & Latest Developments
7.12 Protalix Biotherapeutics Inc
7.12.1 Protalix Biotherapeutics Inc Company Summary
7.12.2 Protalix Biotherapeutics Inc Business Overview
7.12.3 Protalix Biotherapeutics Inc Lysosomal Storage Disorders Major Product Offerings
7.12.4 Protalix Biotherapeutics Inc Lysosomal Storage Disorders Revenue in Global Market (2019-2024)
7.12.5 Protalix Biotherapeutics Inc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Lysosomal Storage Disorders Market Opportunities & Trends in Global Market
Table 2. Lysosomal Storage Disorders Market Drivers in Global Market
Table 3. Lysosomal Storage Disorders Market Restraints in Global Market
Table 4. Key Players of Lysosomal Storage Disorders in Global Market
Table 5. Top Lysosomal Storage Disorders Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Lysosomal Storage Disorders Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Lysosomal Storage Disorders Revenue Share by Companies, 2019-2024
Table 8. Global Companies Lysosomal Storage Disorders Product Type
Table 9. List of Global Tier 1 Lysosomal Storage Disorders Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lysosomal Storage Disorders Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Lysosomal Storage Disorders Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Lysosomal Storage Disorders Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Lysosomal Storage Disorders Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Lysosomal Storage Disorders Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Lysosomal Storage Disorders Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Lysosomal Storage Disorders Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Lysosomal Storage Disorders Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Lysosomal Storage Disorders Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Lysosomal Storage Disorders Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Lysosomal Storage Disorders Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Lysosomal Storage Disorders Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Lysosomal Storage Disorders Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Lysosomal Storage Disorders Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Lysosomal Storage Disorders Revenue, (US$, Mn), 2025-2030
Table 30. Astellas Pharma Company Summary
Table 31. Astellas Pharma Lysosomal Storage Disorders Product Offerings
Table 32. Astellas Pharma Lysosomal Storage Disorders Revenue (US$, Mn) & (2019-2024)
Table 33. Astellas Pharma Key News & Latest Developments
Table 34. Astrazeneca Company Summary
Table 35. Astrazeneca Lysosomal Storage Disorders Product Offerings
Table 36. Astrazeneca Lysosomal Storage Disorders Revenue (US$, Mn) & (2019-2024)
Table 37. Astrazeneca Key News & Latest Developments
Table 38. Actelion Company Summary
Table 39. Actelion Lysosomal Storage Disorders Product Offerings
Table 40. Actelion Lysosomal Storage Disorders Revenue (US$, Mn) & (2019-2024)
Table 41. Actelion Key News & Latest Developments
Table 42. Eli Lilly and Company Company Summary
Table 43. Eli Lilly and Company Lysosomal Storage Disorders Product Offerings
Table 44. Eli Lilly and Company Lysosomal Storage Disorders Revenue (US$, Mn) & (2019-2024)
Table 45. Eli Lilly and Company Key News & Latest Developments
Table 46. Merck & Co Company Summary
Table 47. Merck & Co Lysosomal Storage Disorders Product Offerings
Table 48. Merck & Co Lysosomal Storage Disorders Revenue (US$, Mn) & (2019-2024)
Table 49. Merck & Co Key News & Latest Developments
Table 50. Novo Nordisk Company Summary
Table 51. Novo Nordisk Lysosomal Storage Disorders Product Offerings
Table 52. Novo Nordisk Lysosomal Storage Disorders Revenue (US$, Mn) & (2019-2024)
Table 53. Novo Nordisk Key News & Latest Developments
Table 54. Amicus Therapeutics Company Summary
Table 55. Amicus Therapeutics Lysosomal Storage Disorders Product Offerings
Table 56. Amicus Therapeutics Lysosomal Storage Disorders Revenue (US$, Mn) & (2019-2024)
Table 57. Amicus Therapeutics Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Lysosomal Storage Disorders Product Offerings
Table 60. Pfizer Lysosomal Storage Disorders Revenue (US$, Mn) & (2019-2024)
Table 61. Pfizer Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Lysosomal Storage Disorders Product Offerings
Table 64. Sanofi Lysosomal Storage Disorders Revenue (US$, Mn) & (2019-2024)
Table 65. Sanofi Key News & Latest Developments
Table 66. BioMarin Pharmaceutical Inc. Company Summary
Table 67. BioMarin Pharmaceutical Inc. Lysosomal Storage Disorders Product Offerings
Table 68. BioMarin Pharmaceutical Inc. Lysosomal Storage Disorders Revenue (US$, Mn) & (2019-2024)
Table 69. BioMarin Pharmaceutical Inc. Key News & Latest Developments
Table 70. Raptor Pharmaceuticals Company Summary
Table 71. Raptor Pharmaceuticals Lysosomal Storage Disorders Product Offerings
Table 72. Raptor Pharmaceuticals Lysosomal Storage Disorders Revenue (US$, Mn) & (2019-2024)
Table 73. Raptor Pharmaceuticals Key News & Latest Developments
Table 74. Protalix Biotherapeutics Inc Company Summary
Table 75. Protalix Biotherapeutics Inc Lysosomal Storage Disorders Product Offerings
Table 76. Protalix Biotherapeutics Inc Lysosomal Storage Disorders Revenue (US$, Mn) & (2019-2024)
Table 77. Protalix Biotherapeutics Inc Key News & Latest Developments
List of Figures
Figure 1. Lysosomal Storage Disorders Segment by Type in 2023
Figure 2. Lysosomal Storage Disorders Segment by Application in 2023
Figure 3. Global Lysosomal Storage Disorders Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Lysosomal Storage Disorders Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Lysosomal Storage Disorders Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lysosomal Storage Disorders Revenue in 2023
Figure 8. By Type - Global Lysosomal Storage Disorders Revenue Market Share, 2019-2030
Figure 9. By Application - Global Lysosomal Storage Disorders Revenue Market Share, 2019-2030
Figure 10. By Type - Global Lysosomal Storage Disorders Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Lysosomal Storage Disorders Revenue Market Share, 2019-2030
Figure 12. By Application - Global Lysosomal Storage Disorders Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Lysosomal Storage Disorders Revenue Market Share, 2019-2030
Figure 14. By Region - Global Lysosomal Storage Disorders Revenue Market Share, 2019-2030
Figure 15. By Country - North America Lysosomal Storage Disorders Revenue Market Share, 2019-2030
Figure 16. US Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Lysosomal Storage Disorders Revenue Market Share, 2019-2030
Figure 20. Germany Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 21. France Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Lysosomal Storage Disorders Revenue Market Share, 2019-2030
Figure 28. China Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 32. India Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Lysosomal Storage Disorders Revenue Market Share, 2019-2030
Figure 34. Brazil Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Lysosomal Storage Disorders Revenue Market Share, 2019-2030
Figure 37. Turkey Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Lysosomal Storage Disorders Revenue, (US$, Mn), 2019-2030
Figure 41. Astellas Pharma Lysosomal Storage Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Astrazeneca Lysosomal Storage Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Actelion Lysosomal Storage Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Eli Lilly and Company Lysosomal Storage Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Merck & Co Lysosomal Storage Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Novo Nordisk Lysosomal Storage Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Amicus Therapeutics Lysosomal Storage Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Pfizer Lysosomal Storage Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Sanofi Lysosomal Storage Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. BioMarin Pharmaceutical Inc. Lysosomal Storage Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Raptor Pharmaceuticals Lysosomal Storage Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Protalix Biotherapeutics Inc Lysosomal Storage Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
